Recommend to a friend

Biosimilars in Patients with Crohn’s Disease Failing an Initial Biologic

Upon completion of the activity, participants should be able to explain the circumstances – and rationale – under which it is appropriate to initiate or switch a patient with inflammatory bowel disease to a biosimilar. 2. Explain the circumstances under which it is appropriate to initiate or switch a patient with inflammatory bowel disease to a biosimilar
IL-gastro-case2